Philanthropic Support from Dr. Marie and Mr. Vijay Goradia Enables Research Collaboration to Study 11h in Alzheimer's Disease

Partnership11hPositive

AI Analysis

Summary

Goldenrod Therapeutics and UT Health San Antonio's Glenn Biggs Institute announced a research collaboration supported by philanthropic funding from Dr. Marie and Mr. Vijay Goradia to evaluate an investigational PDE4 inhibitor called 11h in preclinical models of Alzheimer's disease.

Clinical Trial Data

Phase

preclinical

Importance:3/10

Sentiment:

0.50

partnershippreclinicalAlzheimer's diseasePDE4 inhibitorphilanthropic funding

Related Companies

$INTI $HIT

Read the original article

Published by PR Newswire Clinical Trials on September 28, 2026 1:08 PM

Read Original